The smart drug delivery system and its clinical potential

Theranostics

Volumn 6, Issue 9, 2016, Pages 1306-1323

  Liu, Dong ^a   Yang, Fang ^a   Xiong, Fei ^a   Gu, Ning ^a  

^a Southeast University   (United States)

Author keywords

Biomaterials; Controlled release; Drug delivery system (DDS); Nanomedicine; Smart nanoplatform

Indexed keywords

DRUG CARRIER; ENZYME; GLUCOSE; LIPOSOME; MAGNETIC NANOPARTICLE; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; ORGANIC INORGANIC HYBRID SMART NANOPARTICLE; POLYMER; UNCLASSIFIED DRUG;

CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG QUALITY; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; EXOSOME; HUMAN; LIPOSOMAL DELIVERY; MAGNETISM; NANOTECHNOLOGY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PATIENT COMPLIANCE; PH; PHOTOSENSITIVITY; PRECLINICAL STUDY; REPRODUCIBILITY; REVIEW; SMART DRUG DELIVERY SYSTEM; TEMPERATURE SENSITIVITY; TRANSLATIONAL RESEARCH; ULTRASOUND; ANIMAL; DRUG DEVELOPMENT; MOLECULARLY TARGETED THERAPY; PROCEDURES; THERANOSTIC NANOMEDICINE; TRENDS;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; HUMANS; MOLECULAR TARGETED THERAPY; NANOPARTICLES; THERANOSTIC NANOMEDICINE;

EID: 84978656530     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.14858     Document Type: Review

References (195)

1. Hrubý M, Filippov SK, Štěpánek P. Smart polymers in drug delivery systems on crossroads: Which way deserves following? European Polymer Journal. 2015;65:82-97.
2. Kopeček J, Yang J. Hydrogels as smart biomaterials. Polymer International. 2007;56:1078-98.
3. Lee BK, Yun YH, Park K. Smart nanoparticles for drug delivery: Boundaries and opportunities. Chemical Engineering Science. 2015;125:158-64.
4. Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, Fu T, et al. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine. 2012;7:1253-71.
5. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Advanced Drug Delivery Reviews. 2013;65:36-48.
6. Couvreur P. Nanoparticles in drug delivery: past, present and future. Advanced Drug Delivery Reviews. 2013;65:21-3.
7. Alvarez-Lorenzo C, Concheiro A. Smart drug delivery systems: from fundamentals to the clinic. Chemical Communications. 2014;50:7743-65.
8. Crommelin DJ, Florence AT. Towards more effective advanced drug delivery systems. International Journal of Pharmaceutics. 2013;454:496-511.
9. Holzapfel BM, Reichert JC, Schantz J-T, Gbureck U, Rackwitz L, Nöth U, et al. How smart do biomaterials need to be? A translational science and clinical point of view. Advanced Drug Delivery Reviews. 2013;65:581-603.
10. Grund S, Bauer M, Fischer D. Polymers in drug delivery-state of the art and future trends. Advanced Engineering Materials. 2011;13: B61-B87.
11. Annabi N, Tamayol A, Uquillas JA, Akbari M, Bertassoni LE, Cha C, et al. 25th anniversary article: rational design and applications of hydrogels in regenerative medicine. Advanced Materials. 2014;26:85-124.
12. Chang H-I, Yeh M-K. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. International Journal of Nanomedicine. 2012;7:49-60.
13. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and Surfaces B: Biointerfaces. 2010;75:1-18.
14. Rossi F, Ferrari R, Castiglione F, Mele A, Perale G, Moscatelli D. Polymer hydrogel functionalized with biodegradable nanoparticles as composite system for controlled drug delivery. Nanotechnology. 2014;26:015602.
15. Shimoni O, Postma A, Yan Y, Scott AM, Heath JK, Nice EC, et al. Macromolecule functionalization of disulfide-bonded polymer hydrogel capsules and cancer cell targeting. ACS Nano. 2012;6:1463-72.
16. Stumpel JE, Gil ER, Spoelstra AB, Bastiaansen CW, Broer DJ, Schenning AP. Stimuli Responsive Materials Based on Interpenetrating Polymer Liquid Crystal Hydrogels. Advanced Functional Materials. 2015;25:3314-20.
17. Tanaka T. Collapse of gels and the critical endpoint. Physical Review Letters. 1978;40:820.
18. Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science. 1978;202:1290-3.
19. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature Materials. 2013;12:991-1003.
20. Kelley EG, Albert JN, Sullivan MO, Epps III TH. Stimuli-responsive copolymer solution and surface assemblies for biomedical applications. Chemical Society Reviews. 2013;42:7057-71.
21. Liu J, Huang Y, Kumar A, Tan A, Jin S, Mozhi A, et al. pH-Sensitive nano-systems for drug delivery in cancer therapy. Biotechnology Advances. 2014;32:693-710.
22. Ganesh VA, Baji A, Ramakrishna S. Smart functional polymers-a new route towards creating a sustainable environment. RSC Advances. 2014;4:53352-64.
23. Gao W, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Molecular Pharmaceutics. 2010;7:1913-20.
24. Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, et al. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Acta Biomaterialia. 2015;14:115-24.
25. Subudhi MB, Jain A, Jain A, Hurkat P, Shilpi S, Gulbake A, et al. Eudragit S100 coated citrus pectin nanoparticles for colon targeting of 5-Fluorouracil. Materials. 2015;8:832-49.
26. Stubbs M, McSheehy PM, Griffiths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Molecular Medicine Today. 2000;6:15-9.
27. Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nature Reviews Drug Discovery. 2011;10:767-77.
28. Lee ES, Oh KT, Kim D, Youn YS, Bae YH. Tumor pH-responsive flower-like micelles of poly (L-lactic acid)-b-poly (ethylene glycol)-b-poly (L-histidine). Journal of Controlled Release. 2007;123:19-26.
29. Cheng R, Meng F, Deng C, Klok H-A, Zhong Z. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials. 2013;34:3647-57.
30. Pan Y-J, Chen Y-Y, Wang D-R, Wei C, Guo J, Lu D-R, et al. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release. Biomaterials. 2012;33:6570-9.
31. Chen W, Zhong P, Meng F, Cheng R, Deng C, Feijen J, et al. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. Journal of Controlled Release. 2013;169:171-9.
32. Huo M, Yuan J, Tao L, Wei Y. Redox-responsive polymers for drug delivery: from molecular design to applications. Polymer Chemistry. 2014;5:1519-28.
33. Wang J, Sun X, Mao W, Sun W, Tang J, Sui M, et al. Tumor Redox Heterogeneity Responsive Prodrug Nanocapsules for Cancer Chemotherapy. Advanced Materials. 2013;25:3670-6.
34. Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature Reviews Drug Discovery. 2014;13:813-27.
35. Wilson DS, Dalmasso G, Wang L, Sitaraman SV, Merlin D, Murthy N. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. Nature Materials. 2010;9:923-8.
36. Nguyen MM, Carlini AS, Chien MP, Sonnenberg S, Luo C, Braden RL, et al. Enzyme Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction. Advanced Materials. 2015;27:5547-52.
37. Callmann CE, Barback CV, Thompson MP, Hall DJ, Mattrey RF, Gianneschi NC. Therapeutic Enzyme Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors. Advanced Materials. 2015;27:4611-5.
38. De La Rica R, Aili D, Stevens MM. Enzyme-responsive nanoparticles for drug release and diagnostics. Advanced Drug Delivery Reviews. 2012;64:967-78.
39. Lock LL, Tang Z, Keith D, Reyes C, Cui H. Enzyme-Specific Doxorubicin Drug Beacon as Drug-Resistant Theranostic Molecular Probes. ACS Macro Letters. 2015;4:552-5.
40. Shi Y, van den Dungen ET, Klumperman B, van Nostrum CF, Hennink WE. Reversible Addition-Fragmentation Chain Transfer Synthesis of a Micelle-Forming, Structure Reversible Thermosensitive Diblock Copolymer Based on the N-(2-Hydroxy propyl) Methacrylamide Backbone. ACS Macro Letters. 2013;2:403-8.
41. Shi Y, van Steenbergen MJ, Teunissen EA, Novo Ls, Gradmann S, Baldus M, et al. Π-Π stacking increases the stability and loading capacity of thermosensitive polymeric micelles for chemotherapeutic drugs. Biomacromolecules. 2013;14:1826-37.
42. Shi Y, Cardoso RM, Van Nostrum CF, Hennink WE. Anthracene functionalized thermosensitive and UV-crosslinkable polymeric micelles. Polymer Chemistry. 2015;6:2048-53.
43. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. Journal of Controlled Release. 2010;148:135-46.
44. Adelsberger J, Kulkarni A, Jain A, Wang W, Bivigou-Koumba AM, Busch P, et al. Thermoresponsive PS-b-PNIPAM-b-PS micelles: aggregation behavior, segmental dynamics, and thermal response. Macromolecules. 2010;43:2490-501.
45. Zhao Y, Fan X, Liu D, Wang Z. PEGylated thermo-sensitive poly (amidoamine) dendritic drug delivery systems. International Journal of Pharmaceutics. 2011;409:229-36.
46. Lal S, Clare SE, Halas NJ. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Accounts of Chemical Research. 2008;41:1842-51.
47. Sun J, Zhang Y, Chen Z, Zhou J, Gu N. Fibrous Aggregation of Magnetite Nanoparticles Induced by a Time Varied Magnetic Field. Angewandte Chemie International Edition. 2007;46:4767-70.
48. Liu J, Zhang Y, Wang C, Xu R, Chen Z, Gu N. Magnetically sensitive alginate-templated polyelectrolyte multilayer microcapsules for controlled release of doxorubicin. The Journal of Physical Chemistry C. 2010;114:7673-9.
49. Chen Z, Yin J-J, Zhou Y-T, Zhang Y, Song L, Song M, et al. Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. Acs Nano. 2012;6:4001-12.
50. Fang K, Song L, Gu Z, Yang F, Zhang Y, Gu N. Magnetic field activated drug release system based on magnetic PLGA microspheres for chemo-thermal therapy. Colloids and Surfaces B: Biointerfaces. 2015;136:712-20.
51. Yang F, Zhang X, Song L, Cui H, Myers JN, Bai T, et al. Controlled Drug Release and Hydrolysis Mechanism of Polymer-Magnetic Nanoparticle Composite. ACS Applied Materials & Interfaces. 2015;7:9410-9.
52. Hu K, Sun J, Guo Z, Wang P, Chen Q, Ma M, et al. A novel magnetic hydrogel with aligned magnetic colloidal assemblies showing controllable enhancement of magnetothermal effect in the presence of alternating magnetic field. Advanced Materials. 2015;27:2507-14.
53. Wang F, Kim D-K, Yoshitake T, Johansson S, Bjelke B, Muhammed M, et al. Diffusion and clearance of superparamagnetic iron oxide nanoparticles infused into the rat striatum studied by MRI and histochemical techniques. Nanotechnology. 2010;22:015103.
54. Yue-Jian C, Juan T, Fei X, Jia-Bi Z, Ning G, Yi-Hua Z, et al. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Development and Industrial Pharmacy. 2010;36:1235-44.
55. Xie J, Zhang Y, Yan C, Song L, Wen S, Zang F, et al. High-performance PEGylated Mn-Zn ferrite nanocrystals as a passive-targeted agent for magnetically induced cancer theranostics. Biomaterials. 2014;35:9126-36.
56. Xiong F, Chen Y, Chen J, Yang B, Zhang Y, Gao H, et al. Rubik-like magnetic nanoassemblies as an efficient drug multifunctional carrier for cancer theranostics. Journal of Controlled Release. 2013;172:993-1001.
57. Song L, Zang F, Song M, Chen G, Zhang Y. Effective PEGylation of Fe3O4 nanomicelles for in vivo MR imaging. Journal of Nanoscience and Nanotechnology. 2015;15:4111-8.
58. Liu D, Wu W, Chen X, Wen S, Zhang X, Ding Q, et al. Conjugation of paclitaxel to iron oxide nanoparticles for tumor imaging and therapy. Nanoscale. 2012;4:2306-10.
59. Yang H-W, Hua M-Y, Liu H-L, Huang C-Y, Tsai R-Y, Lu Y-J, et al. Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas. Biomaterials. 2011;32:6523-32.
60. Hayashi K, Nakamura M, Sakamoto W, Yogo T, Miki H, Ozaki S, et al. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics. 2013;3:366-76.
61. Paris JL, Cabañas MV, Manzano M, Vallet-Regí M. Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers. ACS Nano. 2015;9:11023-33.
62. Guo Q, Zhang T, An J, Wu Z, Zhao Y, Dai X, et al. Block versus Random Amphiphilic Glycopolymer Nanopaticles as Glucose-Responsive Vehicles. Biomacromolecules. 2015;16:3345-56.
63. Wu Q, Wang L, Yu H, Wang J, Chen Z. Organization of glucose-responsive systems and their properties. Chemical Reviews. 2011;111:7855-75.
64. Gu Z, Aimetti AA, Wang Q, Dang TT, Zhang Y, Veiseh O, et al. Injectable nano-network for glucose-mediated insulin delivery. ACS Nano. 2013;7:4194-201.
65. Murdan S. Electro-responsive drug delivery from hydrogels. Journal of Controlled Release. 2003;92:1-17.
66. Yun J, Im JS, Lee Y-S, Kim H-I. Electro-responsive transdermal drug delivery behavior of PVA/PAA/MWCNT nanofibers. European Polymer Journal. 2011;47:1893-902.
67. Ying X, Wang Y, Liang J, Yue J, Xu C, Lu L, et al. Angiopep Responsive Hydrogel Nanoparticles: Therapeutic Potential for Epilepsy. Angewandte Chemie International Edition. 2014;53:12436-40.
68. Curcio M, Spizzirri UG, Cirillo G, Vittorio O, Picci N, Nicoletta FP, et al. On demand delivery of ionic drugs from electro-responsive CNT hybrid films. RSC Advances. 2015;5:44902-11.
69. Schmaljohann D. Thermo-and pH-responsive polymers in drug delivery. Advanced Drug Delivery Reviews. 2006;58:1655-70.
70. Zhang L, Guo R, Yang M, Jiang X, Liu B. Thermo and pH Dual Cancer Drug Delivery. Advanced Materials. 2007;19:2988-92.
71. Zhang Z, Wang J, Chen C. Near Infrared Light Mediated Nanoplatforms for Cancer Thermo Chemotherapy and Optical Imaging. Advanced Materials. 2013;25:3869-80.
72. Jochum FD, Theato P. Thermo-and light responsive micellation of azobenzene containing block copolymers. Chemical Communications. 2010;46:6717-9.
73. Yang F, Chen P, He W, Gu N, Zhang X, Fang K, et al. Bubble microreactors triggered by an alternating magnetic field as diagnostic and therapeutic delivery devices. Small. 2010;6:1300-5.
74. 2 Nanogenerator for Ultrasound and Magnetic Resonance Dual Modality Imaging. Advanced Materials. 2012;24:5205-11.
75. Yang F, Zhang M, He W, Chen P, Cai X, Yang L, et al. Controlled release of Fe3O4 nanoparticles in encapsulated microbubbles to tumor cells via sonoporation and associated cellular bioeffects. Small. 2011;7:902-10.
76. Yang F, Li M, Cui H, Wang T, Chen Z, Song L, et al. Altering the response of intracellular reactive oxygen to magnetic nanoparticles using ultrasound and microbubbles. Science China Materials. 2015;58:467-80.
77. Cai X, Yang F, Gu N. Applications of magnetic microbubbles for theranostics. Theranostics. 2012;2:103-12.
78. Delcea M, Möhwald H, Skirtach AG. Stimuli-responsive LbL capsules and nanoshells for drug delivery. Advanced Drug Delivery Reviews. 2011;63:730-47.
79. Stuart MAC, Huck WT, Genzer J, Müller M, Ober C, Stamm M, et al. Emerging applications of stimuli-responsive polymer materials. Nature Materials. 2010;9:101-13.
80. Gao GH, Li Y, Lee DS. Environmental pH-sensitive polymeric micelles for cancer diagnosis and targeted therapy. Journal of Controlled Release. 2013;169:180-4.
81. Du J-Z, Mao C-Q, Yuan Y-Y, Yang X-Z, Wang J. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy. Biotechnology Advances. 2014;32:789-803.
82. Meng F, Zhong Y, Cheng R, Deng C, Zhong Z. pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances. Nanomedicine. 2014;9:487-99.
83. Liu R, Li D, He B, Xu X, Sheng M, Lai Y, et al. Anti-tumor drug delivery of pH-sensitive poly (ethylene glycol)-poly (L-histidine-)-poly (L-lactide) nanoparticles. Journal of Controlled Release. 2011;152:49-56.
84. Li H, Li M, Chen C, Fan A, Kong D, Wang Z, et al. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier. International Journal of Pharmaceutics. 2015;495:572-8.
85. Duan X, Xiao J, Yin Q, Zhang Z, Yu H, Mao S, et al. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano. 2013;7:5858-69.
86. Shi Y, van Nostrum CF, Hennink WE. Interfacially Hydrazone Cross-linked Thermosensitive Polymeric Micelles for Acid-Triggered Release of Paclitaxel. ACS Biomaterials Science & Engineering. 2015;1:393-404.
87. Du JZ, Sun TM, Song WJ, Wu J, Wang J. A Tumor Acidity Activated Charge Conversional Nanogel as an Intelligent Vehicle for Promoted Tumoral Cell Uptake and Drug Delivery. Angewandte Chemie International Edition. 2010;122:3703-8.
88. Du J-Z, Du X-J, Mao C-Q, Wang J. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. Journal of the American Chemical Society. 2011;133:17560-3.
89. Yuan YY, Mao CQ, Du XJ, Du JZ, Wang F, Wang J. Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor. Advanced Materials. 2012;24:5476-80.
90. Yang X-Z, Du J-Z, Dou S, Mao C-Q, Long H-Y, Wang J. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery. ACS Nano. 2011;6:771-81.
91. Yang XZ, Du XJ, Liu Y, Zhu YH, Liu YZ, Li YP, et al. Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy. Advanced Materials. 2014;26:931-6.
92. Mo R, Sun Q, Xue J, Li N, Li W, Zhang C, et al. Multistage pH-Responsive Liposomes for Mitochondrial-Targeted Anticancer Drug Delivery. Advanced Liposomes for Mitochondrial Targeted Anticancer Drug Delivery. Advanced Materials. 2012;24:3659-65.
93. Ju C, Mo R, Xue J, Zhang L, Zhao Z, Xue L, et al. Sequential intra-intercellular nanoparticle delivery system for deep tumor penetration. Angewandte Chemie International Edition. 2014;53:6253-8.
94. Zhou K, Wang Y, Huang X, Luby Phelps K, Sumer BD, Gao J. Tunable, Ultrasensitive pH Responsive Nanoparticles Targeting Specific Endocytic Organelles in Living Cells. Angewandte Chemie International Edition. 2011;50:6109-14.
95. Wang Y, Zhou K, Huang G, Hensley C, Huang X, Ma X, et al. A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals. Nature Materials. 2014;13:204-12.
96. Sun H, Guo B, Cheng R, Meng F, Liu H, Zhong Z. Biodegradable micelles with sheddable poly (ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials. 2009;30:6358-66.
97. Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. Journal of Controlled Release. 2008;126:187-204.
98. Son S, Shin E, Kim B-S. Redox-Degradable Biocompatible Hyperbranched Polyglycerols: Synthesis, Copolymerization Kinetics, Degradation, and Biocompatibility. Macromolecules. 2015;48:600-9.
99. Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepato-gastroenterology. 2000;48:743-51.
100. Wang W, Lin J, Cai C, Lin S. Optical properties of amphiphilic copolymer-based self-assemblies. European Polymer Journal. 2015;65:112-31.
101. Lovell JF, Liu TW, Chen J, Zheng G. Activatable photosensitizers for imaging and therapy. Chemical Reviews. 2010;110:2839-57.
102. Farhadi A, Roxin Á, Wilson BC, Zheng G. Nano-enabled SERS reporting photosensitizers. Theranostics. 2015;5:469.
103. Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nature Materials. 2011;10:324-32.
104. Wang F, Banerjee D, Liu Y, Chen X, Liu X. Upconversion nanoparticles in biological labeling, imaging, and therapy. Analyst. 2010;135:1839-54.
105. Liu Q, Yin B, Yang T, Yang Y, Shen Z, Yao P, et al. A general strategy for biocompatible, high-effective upconversion nanocapsules based on triplet-triplet annihilation. Journal of the American Chemical Society. 2013;135:5029-37.
106. Liu T-Y, Hu S-H, Liu D-M, Chen S-Y, Chen I-W. Biomedical nanoparticle carriers with combined thermal and magnetic responses. Nano Today. 2009;4:52-65.
107. Kim H, Kang YJ, Kang S, Kim KT. Monosaccharide-responsive release of insulin from polymersomes of polyboroxole block copolymers at neutral pH. Journal of the American Chemical Society. 2012;134:4030-3.
108. Bonnet V, Gervaise C, Djedaïni-Pilard F, Furlan A, Sarazin C. Cyclodextrin nanoassemblies: a promising tool for drug delivery. Drug Discovery Today. 2015;20:1120-6.
109. Ryu JH, Hong S, Lee H. Bio-inspired adhesive catechol-conjugated chitosan for biomedical applications: A mini review. Acta Biomaterialia. 2015;27:101-15.
110. Bangham A, Standish MM, Watkins J. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology. 1965;13:238-327.
111. Deamer DW. From "Banghasomes" to liposomes: A memoir of Alec Bangham, 1921-2010. The FASEB Journal. 2010;24:1308-10.
112. Gregoriadis G, Ryman B. Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochemical Journal. 1971;124:58P.
113. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: classification, preparation, and applications. Nanoscale Research Letters. 2013;8:102.
114. Torchilin V. Liposomes in drug delivery. Fundamentals and Applications of Controlled Release Drug Delivery: Springer; 2012: p289-328.
115. Barenholz YC. Doxil®-the first FDA-approved nano-drug: lessons learned. Journal of Controlled Release. 2012;160:117-34.
116. Bibi S, Lattmann E, Mohammed AR, Perrie Y. Trigger release liposome systems: local and remote controlled delivery? Journal of Microencapsulation. 2012;29:262-76.
117. Sawant RR, Torchilin VP. Liposomes as 'smart'pharmaceutical nanocarriers. Soft Matter. 2010;6:4026-44.
118. Park JW. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Research. 2002;4:95.
119. Clemons KV, Stevens DA. Comparative efficacies of four amphotericin B formulations-Fungizone, Amphotec (Amphocil), AmBisome, and Abelcet against systemic murine aspergillosis. Antimicrobial Agents and Chemotherapy. 2004;48:1047-50.
120. Petre CE, Dittmer DP. Liposomal daunorubicin as treatment for Kaposi's sarcoma. International Journal of Nanomedicine. 2007;2:277.
121. Chamberlain MC. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series. Journal of Neuro-oncology. 2012;109:143-8.
122. Nicolini A, Giardino R, Carpi A, Ferrari P, Anselmi L, Colosimo S, et al. Metastatic breast cancer: an updating. Biomedicine & Pharmacotherapy. 2006;60:548-56.
123. Barnes LD, Giuliano EA, Ota J. Cellular localization of Visudyne® as a function of time after local injection in an in vivo model of squamous cell carcinoma: an investigation into tumor cell death. Veterinary Ophthalmology. 2010;13:158-65.
124. Zhang Q, Huang X-E, Gao L-L. A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors. Biomedicine & Pharmacotherapy. 2009;63:603-7.
125. Silverman JA, Deitcher SR. Marqibo®(vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemotherapy and Pharmacology. 2013;71:555-64.
126. Chen K-J, Chaung E-Y, Wey S-P, Lin K-J, Cheng F, Lin C-C, et al. Hyperthermia-mediated local drug delivery by a bubble-generating liposomal system for tumor-specific chemotherapy. ACS Nano. 2014;8:5105-15.
127. Kono K, Ozawa T, Yoshida T, Ozaki F, Ishizaka Y, Maruyama K, et al. Highly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specific chemotherapy. Biomaterials. 2010;31:7096-105.
128. Pradhan P, Giri J, Rieken F, Koch C, Mykhaylyk O, Döblinger M, et al. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. Journal of Controlled Release. 2010;142:108-21.
129. Simões S, Moreira JN, Fonseca C, Düzgüneş N, Pedroso de Lima MC. On the formulation of pH-sensitive liposomes with long circulation times. Advanced Drug Delivery Reviews. 2004;56:947-65.
130. Obata Y, Tajima S, Takeoka S. Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo. Journal of Controlled Release. 2010;142:267-76.
131. Chiang Y-T, Lo C-L. pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy. Biomaterials. 2014;35:5414-24.
132. Cuomo F, Lopez F, Ceglie A, Maiuro L, Miguel MG, Lindman B. pH-responsive liposome-templated polyelectrolyte nanocapsules. Soft Matter. 2012;8:4415-20.
133. Wan Y, Han J, Fan G, Zhang Z, Gong T, Sun X. Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity. Biomaterials. 2013;34:3020-30.
134. Zhu G, Mock JN, Aljuffali I, Cummings BS, Arnold RD. Secretory phospholipase A2 responsive liposomes. Journal of Pharmaceutical Sciences. 2011;100:3146-59.
135. Huang S-L. Ultrasound-responsive liposomes. Liposomes: Methods and Protocols, Volume 1: Pharmaceutical Nanocarriers. 2010:113-28.
136. Yudina A, De Smet M, Lepetit-Coiffe M, Langereis S, Van Ruijssevelt L, Smirnov P, et al. Ultrasound-mediated intracellular drug delivery using microbubbles and temperature-sensitive liposomes. Journal of Controlled Release. 2011;155:442-8.
137. Klibanov AL, Shevchenko TI, Raju BI, Seip R, Chin CT. Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery. Journal of Controlled Release. 2010;148:13-7.
138. Paasonen L, Sipilä T, Subrizi A, Laurinmäki P, Butcher SJ, Rappolt M, et al. Gold-embedded photosensitive liposomes for drug delivery: triggering mechanism and intracellular release. Journal of Controlled Release. 2010;147:136-43.
139. Leung SJ, Romanowski M. Light-activated content release from liposomes. Theranostics. 2012;2:1020-36.
140. Skupin-Mrugalska P, Piskorz J, Goslinski T, Mielcarek J, Konopka K, Düzgüneş N. Current status of liposomal porphyrinoid photosensitizers. Drug Discovery Today. 2013;18:776-84.
141. Mikhaylov G, Mikac U, Magaeva AA, Itin VI, Naiden EP, Psakhye I, et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nature Nanotechnology. 2011;6:594-602.
142. de Smet M, Heijman E, Langereis S, Hijnen NM, Grüll H. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. Journal of Controlled Release. 2011;150:102-10.
143. de Smet M, Langereis S, van den Bosch S, Grüll H. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. Journal of Controlled Release. 2010;143:120-7.
144. Sanchez C, Julián B, Belleville P, Popall M. Applications of hybrid organic-inorganic nanocomposites. Journal of Materials Chemistry. 2005;15:3559-92.
145. Yang P, Gai S, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chemical Society Reviews. 2012;41:3679-98.
146. Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI. Mesoporous silica nanoparticles in biomedical applications. Chemical Society Reviews. 2012;41:2590-605.
147. Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Advanced Materials. 2012;24:1504-34.
148. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small. 2010;6:1952-67.
149. Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. Journal of the American Chemical Society. 2007;129:7661-5.
150. Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA. The golden age: gold nanoparticles for biomedicine. Chemical Society Reviews. 2012;41:2740-79.
151. Mieszawska AJ, Mulder WJ, Fayad ZA, Cormode DP. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Molecular Pharmaceutics. 2013;10:831-47.
152. Sun T-M, Wang Y-C, Wang F, Du J-Z, Mao C-Q, Sun C-Y, et al. Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds. Biomaterials. 2014;35:836-45.
153. Wang F, Wang Y-C, Dou S, Xiong M-H, Sun T-M, Wang J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. Acs Nano. 2011;5:3679-92.
154. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chemical Society Reviews. 2012;41:2256-82.
155. Wang C, Cheng L, Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials. 2011;32:1110-20.
156. Tsang M-K, Bai G, Hao J. Stimuli responsive upconversion luminescence nanomaterials and films for various applications. Chemical Society Reviews. 2015;44:1585-607.
157. Amstad E, Kohlbrecher J, Müller E, Schweizer T, Textor M, Reimhult E. Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes. Nano Letters. 2011;11:1664-70.
158. Sailor MJ, Park JH. Hybrid nanoparticles for detection and treatment of cancer. Advanced Materials. 2012;24:3779-802.
159. Hagisawa K, Nishioka T, Suzuki R, Maruyama K, Takase B, Ishihara M, et al. Thrombus-targeted perfluorocarbon containing liposomal bubbles for enhancement of ultrasonic thrombolysis: in vitro and in vivo study. Journal of Thrombosis and Haemostasis. 2013;11:1565-73.
160. Lu W, Huang Q, Ku G, Wen X, Zhou M, Guzatov D, et al. Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials. 2010;31:2617-26.
161. Giret S, Wong Chi Man M, Carcel C. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery. Chemistry - A European Journal. 2015;21:13850-65.
162. Baek S, Singh RK, Khanal D, Patel KD, Lee E-J, Leong KW, et al. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles. Nanoscale. 2015;7:14191-216.
163. Patel K, Angelos S, Dichtel WR, Coskun A, Yang Y-W, Zink JI, et al. Enzyme-responsive snap-top covered silica nanocontainers. Journal of the American Chemical Society. 2008;130:2382-3.
164. Mondragón L, Mas N, Ferragud V, de la Torre C, Agostini A, Martínez-Máñez R, et al. Enzyme responsive intracellular controlled release using silica mesoporous nanoparticles capped with ε Poly-L-lysine. Chemistry - A European Journal. 2014;20:5271-81.
165. Coll C, Mondragón L, Martínez Máñez R, Sancenón F, Marcos MD, Soto J, et al. Enzyme Mediated Controlled Release Systems by Anchoring Peptide Sequences on Mesoporous Silica Supports. Angewandte Chemie International Edition. 2011;50:2138-40.
166. Bernardos A, Mondragón L, Javakhishvili I, Mas N, de la Torre C, Martínez Máñez R, et al. Azobenzene Polyesters Used as Gate Like Scaffolds in Nanoscopic Hybrid Systems. Chemistry-A European Journal. 2012;18:13068-78.
167. Liu H, Liu T, Wu X, Li L, Tan L, Chen D, et al. Targeting gold nanoshells on silica nanorattles: a drug cocktail to fight breast tumors via a single irradiation with near infrared laser light. Advanced Materials. 2012;24:755-61.
168. 4 core hybrid Aushell nanocomposite for bimodal imaging and photothermal therapy. Advanced Materials. 2011;23:5392-7.
169. Yeh Y-C, Creran B, Rotello VM. Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale. 2012;4:1871-80.
170. Kojima C, Hirano Y, Yuba E, Harada A, Kono K. Preparation and characterization of complexes of liposomes with gold nanoparticles. Colloids and Surfaces B: Biointerfaces. 2008;66:246-52.
171. Umeda Y, Kojima C, Harada A, Horinaka H, Kono K. PEG-attached PAMAM dendrimers encapsulating gold nanoparticles: growing gold nanoparticles in the dendrimers for improvement of their photothermal properties. Bioconjugate Chemistry. 2010;21:1559-64.
172. Yang F, Li Y, Chen Z, Zhang Y, Wu J, Gu N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials. 2009;30:3882-90.
173. Yang F, Li M, Liu Y, Wang T, Feng Z, Cui H, et al. Glucose and magnetic-responsive approach toward in situ nitric oxide bubbles controlled generation for hyperglycemia theranostics. Journal of Controlled Release. 2016;228:87-95.
174. Sun D, Zhuang X, Zhang S, Deng Z-B, Grizzle W, Miller D, et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Advanced Drug Delivery Reviews. 2013;65:342-7.
175. Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. Journal of Controlled Release. 2015;219:396-405.
176. van Dommelen SM, Vader P, Lakhal S, Kooijmans S, van Solinge WW, Wood MJ, et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. Journal of Controlled Release. 2012;161:635-44.
177. Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M. A comprehensive overview of exosomes as drug delivery vehicles-endogenous nanocarriers for targeted cancer therapy. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2014;1846:75-87.
178. Tan A, Rajadas J, Seifalian AM. Exosomes as nano-theranostic delivery platforms for gene therapy. Advanced Drug Delivery Reviews. 2013;65:357-67.
179. Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, et al. Exosomes as drug delivery vehicles for Parkinson's disease therapy. Journal of Controlled Release. 2015;207:18-30.
180. Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35:2383-90.
181. Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, Choo A, et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. Journal of Translational Medicine. 2011;9:1471-82.
182. Kopeček J. Smart and genetically engineered biomaterials and drug delivery systems. European Journal of Pharmaceutical Sciences. 2003;20:1-16.
183. Lavan DA, McGuire T, Langer R. Small-scale systems for in vivo drug delivery. Nature Biotechnology. 2003;21:1184-91.
184. Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnology. 2015;33:941-51.
185. Lindner LH, Hossann M, Vogeser M, Teichert N, Wachholz K, Eibl H, et al. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release. Journal of Controlled Release. 2008;125:112-20.
186. Shaffer SA, Baker-Lee C, Kennedy J, Lai MS, de Vries P, Buhler K, et al. In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases. Cancer Chemotherapy and Pharmacology. 2007;59:537-48.
187. Gil PR, Hühn D, Loretta L, Sasse D, Parak WJ. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. Pharmacological Research. 2010;62:115-25.
188. Schwartz JA, Shetty AM, Price RE, Stafford RJ, Wang JC, Uthamanthil RK, et al. Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model. Cancer Research. 2009;69:1659-67.
189. Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine: Nanotechnology, Biology and Medicine. 2013;9:1-14.
190. Ferrari M. Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends in Biotechnology. 2010;28:181-8.
191. Helmus MN. The need for rules and regulations. Nature Nanotechnology. 2007;2:333-4.
192. Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. Journal of Controlled Release. 2015;200:138-57.
193. Begley CG, Ellis LM. Drug development: Raise standards for preclinical cancer research. Nature. 2012;483:531-3.
194. Hunter KW. Mouse models of cancer: does the strain matter? Nature Reviews Cancer. 2012;12:144-9.
195. Teicher BA. Tumor models for efficacy determination. Molecular Cancer Therapeutics. 2006;5:2435-43.